CVR: 38277022
Previous names: SEPAS Health IVS
DKK 0
Gross profit
Net result: DKK 0
No owners listed
CVR · view ownership and management
Director role ended: Michael Kayser
CVR · 10/11/2021
View the full event history
B:Havior IVS was a Danish company of the type Iværksætterselskab based in Rødovre, founded in 2016 and dissolved in 2021. The company was registered under the industry Sundhedsvæsen i øvrigt i.a.n.. The company was previously named SEPAS Health IVS. In 2020, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -3,125 the year before. Equity in the 2020 report amounted to DKK 0.
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreNo. B:Havior IVS is registered in the Danish CVR register with the status Dissolved and ceased on 10 November 2021.
B:Havior IVS was founded on 20 December 2016.
B:Havior IVS was registered under the industry Sundhedsvæsen i øvrigt i.a.n. (industry code 869090).
In 2020, B:Havior IVS reported a gross profit of DKK 0.
B:Havior IVS was located at c/o B:Havior, Valhøjs Alle 189B, 2610 Rødovre.
The CVR number of B:Havior IVS is 38277022.
As of November 10, 2021, Michael Kayser has stepped down as adm. dir. of B:Havior IVS.
B:Havior IVS was dissolved on November 10, 2021.
B:Havior IVS has published its annual report for 2020. Gross profit came to DKK 0, and the net result was DKK 0.
B:Havior IVS has published its annual report for 2019. Gross profit came to DKK -3,125, and the net result was DKK -3,125.
As of September 3, 2019, Michael Kayser is registered as adm. dir. of B:Havior IVS.
As of September 3, 2019, Mathias Haastrup has stepped down as adm. dir. of B:Havior IVS.
B:Havior IVS has published its annual report for 2018. Revenue came to DKK 102,950, and the net result was DKK 18,859.
On June 10, 2019, the company changed its name from SEPAS Health IVS to B:Havior IVS.
As of June 1, 2019, Mathias Haastrup is registered as adm. dir. of B:Havior IVS.
As of May 31, 2019, Niklas Windolf-Vestergaard has stepped down as adm. dir. of B:Havior IVS.
B:Havior IVS has published its annual report for 2017. Revenue came to DKK 0, and the net result was DKK 0.
As of December 20, 2016, Niklas Windolf-Vestergaard is registered as adm. dir. of B:Havior IVS.
B:Havior IVS was founded on December 20, 2016.
